PRFX - PainReform Corp Sales Growth YoY (TTM)

Graphic logo of PainReform Corp (PRFX)

Drug delivery method patents create significant barriers for competitors, as evidenced by the TTM 12-month year-over-year revenue change, where the metric level stands at 0.00. Surgeon loyalty to PRF-110 strengthens the image of PainReform Ltd. (PRFX), although FDA approval risks and PLFE commercialization costs remain significant factors for investors.

Sales Growth YoY (Last Twelve Months): PainReform Corp (PRFX) for 02/11/2024 - 11/16/2026

PainReform Corp (PRFX) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Summary company analytics:PainReform Corp, PRFX
Brand item of PainReform Limited

PainReform Ltd. operates in the high-risk anesthetic development sector, where commercial success is constrained by fierce competition and a shortage of funding for final trials. This indicator measures the relative change in revenue over a rolling twelve-month period, allowing investors to assess product demand and business predictability through the dynamics of TTM revenue growth rates compared to the previous year.

Competitors of PainReform Ltd. (PRFX)

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|Eupraxia Pharmaceuticals - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) BioHarvest Sciences Inc. BHST|EXOZ: Sales Growth YoY (TTM)|Oramed (ORMP) - Sales Growth YoY (TTM)|ENTX (Entera Bio) - Sales Growth YoY (TTM)|ipatherapeutics.com (HYFT) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Trailing Twelve Months Revenue Growth|TELO: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Sales Growth YoY (Last Twelve Months)|RLYB - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Lexaria Bioscience|Pulmatrix Corp - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) LYRA (Lyra Therapeutics Inc.)|Annual Revenue Growth (Last Twelve Months) Impact BioMedical (IBO)|TNF Pharmaceuticals - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cbdMD Inc.|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)